Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety Study of Refrigerator-stable VARIVAX in Infants
NCT00432731Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2004
- Primary completion
- Sep 2005
- Modality
- Prophylactic Vaccines, DNA Vaccines, Live Biotherapeutic Products
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial of varicella virus vaccine live in varicella (VZV) (2 arms), sponsored by Merck & Co. Primary endpoints: Safety profile of refrigerator-stable VARIVAX at 42 days, Solicited injection-site reactions and 1 more. Started Dec 2004; status: completed.
02
Drugs
varicella virus vaccine live
03
Conditions
varicella (VZV)
Beyond the preview
Go deeper on NCT00432731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00432731.